Educational Video for Prostate Cancer

Recruiting in Palo Alto (17 mi)

Age: 18+

Sex: Male

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Recruiting

Sponsor: Henry Ford Health System

Disqualifiers: Prior germline testing, Positive somatic test

No Placebo Group

Trial Summary

What is the purpose of this trial?

This is a pilot study to improve rates of germline genetic testing for black patients with aggressive prostate cancer as recommended by the updated guidelines by the National Cancer Comprehensive Network (NCCN) in 2018. In this study, consented patients will undergo a low-risk intervention of an educational session with a trained staff member on germline testing in prostate cancer and, if agreeable, subsequent germline cancer genetic testing via a commercial lab test.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It seems focused on educational sessions and genetic testing, so it's unlikely that your medications will be affected.

What data supports the effectiveness of the treatment Educational video for prostate cancer?

Research shows that educational videos can help patients understand prostate cancer screening and treatment, improve their participation in decision-making, and manage post-treatment complications effectively. Additionally, video education has been found to maintain high patient satisfaction and potentially reduce hospital discharge delays after surgery. ^{1 2 3 4 5}

Is the educational video for prostate cancer safe for humans?

The educational video for prostate cancer is designed to help patients understand their treatment options and does not involve any physical treatment or medication, so it is generally safe for humans. ^{1 6 7 8 9}

How does the educational video treatment for prostate cancer differ from other treatments?

The educational video treatment is unique because it focuses on providing patients with information about prostate cancer and its treatment options through an engaging and accessible format, helping them make informed decisions. Unlike traditional medical treatments, this approach emphasizes patient education and involvement in the decision-making process. ^{1 6 8 10 11}

Eligibility Criteria

This trial is for black or multiracial men including black, aged 18+, with high-risk prostate cancer. They should meet NCCN guidelines for germline testing and have a significant family history of certain cancers or a diagnosis of aggressive prostate cancer regardless of family history. Men who've already had genetic testing are excluded.

Inclusion Criteria

I am a man with low to intermediate risk prostate cancer and have a significant family history of cancer.

I am a man aged 18 or older.

I am a man with high-risk or very high-risk prostate cancer, including if it has spread to lymph nodes or is metastatic.

Exclusion Criteria

I have undergone genetic testing.

My genetic test shows a possible inherited variant.

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Educational Intervention

Participants undergo a one-on-one in-person education session regarding germline testing in prostate cancer, including pre- and post-intervention questionnaires.

1 day

1 visit (in-person)

Genetic Testing

Participants who agree to proceed with testing will undergo germline cancer genetic testing via a commercial lab test.

Varies

Follow-up

Participants are monitored for the impact of genetic testing results on clinical management, including clinician surveys.

24 months

Treatment Details

Interventions

• Educational video (Behavioral Intervention)

Trial Overview The study tests whether an educational video can increase the completion rates of recommended genetic testing in black patients with high-risk prostate cancer. Participants will watch an educational session and may then undergo genetic testing.

Participant Groups

Group I: Educational intervention Experimental Treatment 1 Intervention

Patients will be asked questions about genetic testing for prostate cancer before and after an educational intervention.

Find a Clinic Near You

Research Locations Nearby Select from list below to view details:

Henry Ford Cancer Pavilion Detroit, MI

Who Is Running the Clinical Trial?

Henry Ford Health System Lead Sponsor

References

1. United States pubmed.ncbi.nlm.nih.gov

Efficacy of a video for teaching patients about prostate cancer screening and treatment. [2018] To test the effectiveness of a video to teach patients about prostate cancer screening and treatment in a clinic setting.

2. United States pubmed.ncbi.nlm.nih.gov

Managing the low-socioeconomic-status prostate cancer patient. [2021] Management of patients with low socioeconomic status and/or low literacy who have prostate cancer presents a challenge to healthcare professionals. Improving treatment outcomes for these men requires specific educational programs to provide a better understanding of prostate cancer including careful posttreatment follow-up to ensure they have recovered well, that the cancer is not progressing and that complications are not proving troublesome. Practice nurses and health educators/navigators can play an important role in achieving these objectives. Education and knowledgeable advice can lead to earlier diagnosis of prostate cancer, improved patient participation in the treatment decision-making process and effective management of posttreatment complications.

3. Ireland pubmed.ncbi.nlm.nih.gov

Psychosocial and educational aspects in prostate cancer patients. [2019] Prostate cancer was a neglected area in psycho-oncology. There is now a growing number of studies on the psychosocial aspects of having prostate cancer and the possibilities to reduce these problems in educational and group interventions. In this issue of Patient Education and Counseling, studies are presented on several psychosocial and educational aspects in prostate cancer patients: screening events and outcomes, assessing the unmet information, support and care delivery needs, reacting to the diagnosis of prostate cancer, informational needs of men on hormonal therapy, changes in health-related quality of life three months after the diagnosis, information-seeking behaviors and information needs of partners, quality of leaflets, video information in decision making, and patient perceptions and priorities in a rehabilitation program. Conclusions are presented on neglected research areas in psychosocial and educational aspects of living with prostate cancer.

4. Ireland pubmed.ncbi.nlm.nih.gov

Multimedia support in preoperative patient education for radical prostatectomy: the physicians' point of view. [2019] To systematically assess the physicians' point of view of multimedia support in preoperative patient education for radical prostatectomy.

5. Canada pubmed.ncbi.nlm.nih.gov

Use of video education in postoperative patient counselling: A quality improvement initiative. [2022] This quality improvement study examined if a video-based resource could reduce delayed discharges after robotic prostatectomy while maintaining high levels of patient satisfaction.

6. Canada pubmed.ncbi.nlm.nih.gov

Acceptability and preliminary feasibility of an internet/CD-ROM-based education and decision program for early-stage prostate cancer patients: randomized pilot study. [2021] Prostate cancer is the most common cancer affecting men in the United States. Management options for localized disease exist, yet an evidence-based criterion standard for treatment still has to emerge. Although 5-year survival rates approach 98%, all treatment options carry the possibility for significant side effects, such as erectile dysfunction and urinary incontinence. It is therefore recommended that patients be actively involved in the treatment decision process. We have developed an Internet/CD-ROM-based multimedia Prostate Interactive Educational System (PIES) to enhance patients' treatment decision making. PIES virtually mirrors a health center to provide patients with information about prostate cancer and its treatment through an intuitive interface, using videos, animations, graphics, and texts.

7. United States pubmed.ncbi.nlm.nih.gov

Patient-Reported Outcomes Through 5 Years for Active Surveillance, Surgery, Brachytherapy, or External Beam Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer. [2022] Understanding adverse effects of contemporary treatment approaches for men with favorable-risk and unfavorable-risk localized prostate cancer could inform treatment selection.

8. Germany pubmed.ncbi.nlm.nih.gov

Does YouTube include high-quality resources for training on laparoscopic and robotic radical prostatectomy? [2021] Our aim was to assess the educational quality of the YouTube video content related to laparoscopic and robotic radical prostatectomy (RP).

9. United States pubmed.ncbi.nlm.nih.gov

Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years. [2022] Understanding the adverse effects of contemporary approaches to localized prostate cancer treatment could inform shared decision making.

10. United States pubmed.ncbi.nlm.nih.gov

Psychosocial and educational intervention trials in prostate cancer. [2019] To describe the nature and focus of published educational intervention trials in prostate cancer in the last 10 years and to examine the state of the research in this particular area of knowledge.

11. United States pubmed.ncbi.nlm.nih.gov

A Content Analysis of YouTube™ Videos Related to Prostate Cancer. [2019] In the United States, prostate cancer is the most common type of cancer in men after skin cancer. There is a paucity of research devoted to the types of prostate cancer information available on social media outlets. YouTube™ is a widely used video sharing website, which is emerging as commonplace for information related to health. The purpose of this study was to describe the most widely viewed YouTube™ videos related to prostate cancer. The 100 videos were watched a total of 50,278,770 times. The majority of videos were uploaded by consumers (45.0%) and medical or government professionals (30%). The purpose of most videos (78.0%) was to provide information, followed by discussions of prostate cancer treatment (51%) and prostate-specific antigen testing and routine screening (26%). All videos uploaded by medical and government professionals and 93.8% of videos uploaded by news sources provided information compared with about two thirds of consumer and less than one half of commercial and advertisement videos ( p